Familial hyperaldosteronism type II
Synonyms: FH-II · FH2 · Familial hyperaldosteronism type 2
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal dominant
- Age of onset
- Adult
- Status
- active
A heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, non-glucocorticoid remediable hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA) and increased aldosterone-to-renin ratio.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Familial hyperaldosteronism type II | FH-II · FH2 · Familial hyperaldosteronism type 2 |
| fr | Hyperaldostéronisme familial type II | FH-II · FH2 · Hyperaldostéronisme familial type 2 |
| de | Hyperaldosteronismus, familiärer, Typ II | FH-II · FH2 · Familiärer Hyperaldosteronismus, Typ 2 |
| es | Hiperaldosteronismo familiar tipo II | FH-II · FH2 · Hiperaldosteronismo familiar tipo 2 |
| it | Iperaldosteronismo familiare, tipo II | FH-II · FH2 · Iperaldosteronismo familiare, tipo 2 |
| nl | Familiaal hyperaldosteronisme type II | FH-II · FH2 · Familiaal hyperaldosteronisme type 2 |
| pt | Hiperaldosteronismo familiar tipo II | FH-II · FH2 · Hiperaldosteronismo familiar tipo 2 |
| pl | Rodzinny hiperaldosteronizm typu II | FH2 · FH-II · Rodzinny gruczolak nadnerczy · Rodzinny hiperaldosteronizm typu 2 |
| cs | Familiární hyperaldosteronismus, typ II | FH-II · FH2 · Familiární adrenální adenom · Familiární hyperaldosteronismus, typ 2 |
| uk | Сімейний гіперальдостеронізм, тип II | Сімейна аденома надниркових залоз · Сімейний гіперальдостеронізм 2 типу · FH2 · FH-II |
| zh | 家族性醛固酮增多症II型 | 家族性醛固酮增多症II型 |
| tr | Ailesel hiperaldosteronizm tip II | FH2 · FH-II · Ailesel adrenal adenom · Ailesel hiperaldosteronizm tip 2 |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 605635 | E | validated | |
| ICD-10 | E26.0 | NTBT | inclusion | validated |
| ICD-11 | 5A72.0 | NTBT | index | validated |
| MONDO | 0011576 | E | validated | |
| MeSH | C565312 | E | validated | |
| UMLS | C1854107 | E | validated | |
| GARD | 2789 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (3):
- ORPHA:100091Adrenal/paraganglial tumor
rare endocrine diseases; rare neoplastic diseases - ORPHA:235936Familial hyperaldosteronism
rare genetic diseases; rare renal diseases; rare endocrine diseases; rare transplant-related disorders - ORPHA:271847Genetic neuroendocrine tumor
rare genetic diseases
No children.
Genes
1 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| CLCN2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2020 | ENSG00000114859 | 600570 | 3q27.1 | chloride voltage-gated channel 2 | 29403011[PMID] |
Prevalence and incidence
1 record| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
14 annotations · validated 2016-08-29| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Obligate (100%) | ||
| HP:0000822 | Hypertension | |
| Very frequent (99-80%) | ||
| HP:0040084 | Abnormal circulating renin | |
| HP:0011740 | Glucocortocoid-insensitive primary hyperaldosteronism | |
| Frequent (79-30%) | ||
| HP:0011746 | Secretory adrenocortical adenoma | |
| Occasional (29-5%) | ||
| HP:0008221 | Adrenal hyperplasia | |
| HP:0000421 | Epistaxis | |
| HP:0002315 | Headache | |
| HP:0002900 | Hypokalemia | |
| HP:0002170 | Intracranial hemorrhage | |
| HP:0200114 | Metabolic alkalosis | |
| HP:0001324 | Muscle weakness | |
| HP:0002018 | Nausea | |
| HP:0000360 | Tinnitus | |
| Excluded (0%) | ||
| HP:0011739 | Dexamethasone-suppresible primary hyperaldosteronism | |
Run the differential on the 3 obligate / very frequent terms
Annotation source: 20927129[PMID]_26934393[PMID]_27036860[PMID]_25667376[PMID]_20927129[PMID]_1521363[PMID]_9745430[PMID]_11073536[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/404
- This record as JSON: /data/d/404.json